Peterson J A, Tian B, Geiger B, Kaufman P L
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, USA.
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):631-8.
To determine the effect of latrunculin (LAT)-A, which binds to G-actin and disassembles actin filaments, on the pupil, accommodation, and isolated ciliary muscle (CM) contraction in monkeys.
Pupil diameter (vernier calipers) and refraction (coincidence refractometry) were measured every 15 minutes from 0.75 to 3.5 hours after topical LAT-A 42 microg (approximately 10 microM in the anterior chamber [AC]). Refraction was measured every 5 minutes from 0.5 to 1.5 hours after intracameral injection of 10 microl of 50 microM LAT-A (approximately 5 microM in AC), with intramuscular infusion of 1.5 mg/kg pilocarpine HCl (PILO) during the first 15 minutes of measurements. Pupil diameter was measured at 1 and 2 hours, and refraction was measured every 5 minutes from 1 to 2 hours, after intravitreal injection of 20 microl of 1.25 mM LAT-A (approximately 10 microM in vitreous), with intramuscular infusion of 1.5 mg/kg PILO during the first 15 minutes of measurements (all after topical 2.5% phenylephrine), and contractile response of isolated CM strips, obtained <1 hour postmortem and mounted in a perfusion apparatus, to 10 microM PILO +/- LAT-A was measured at various concentrations.
Topical LAT-A of 42 microg dilated the pupil without affecting refraction. Intracameral LAT-A of 5 microM inhibited miotic and accommodative responses to intramuscular PILO. Intravitreal LAT-A of 10 microM had no effect on accommodative or miotic responses to intramuscular PILO. LAT-A dose-dependently relaxed the PILO-contracted CM by up to 50% at 3 microM in both the longitudinal and circular vectors.
In monkeys, LAT-A causes mydriasis and cycloplegia, perhaps related to its known ability to disrupt the actin microfilament network and consequently to affect cell contractility and adhesion. Effects of LAT-A on the iris and CM may have significant physiological and clinical implications.
确定与G-肌动蛋白结合并拆解肌动蛋白丝的拉春库林(LAT)-A对猴子瞳孔、调节功能及离体睫状肌(CM)收缩的影响。
局部应用42微克LAT-A(前房[AC]中约为10微摩尔)后,在0.75至3.5小时内每隔15分钟测量瞳孔直径(游标卡尺)和屈光度数(重合验光法)。前房内注射10微升50微摩尔/升LAT-A(AC中约为5微摩尔)后,在0.5至1.5小时内每隔5分钟测量屈光度数,在测量的前15分钟内肌肉注射1.5毫克/千克盐酸毛果芸香碱(PILO)。玻璃体内注射20微升1.25毫摩尔/升LAT-A(玻璃体内约为10微摩尔)后,在1小时和2小时测量瞳孔直径,在1至2小时内每隔5分钟测量屈光度数,在测量的前15分钟内肌肉注射1.5毫克/千克PILO(均在局部应用2.5%去氧肾上腺素后),并测量死后<1小时获取并安装在灌注装置中的离体CM条对10微摩尔/升PILO ± LAT-A在不同浓度下的收缩反应。
局部应用42微克LAT-A使瞳孔散大,而不影响屈光。前房内5微摩尔LAT-A抑制了对肌肉注射PILO的缩瞳和调节反应。玻璃体内10微摩尔LAT-A对肌肉注射PILO的调节或缩瞳反应无影响。在纵向和环向向量中,LAT-A在3微摩尔时剂量依赖性地使PILO收缩的CM松弛高达50%。
在猴子中,LAT-A可导致瞳孔散大和睫状肌麻痹,这可能与其破坏肌动蛋白微丝网络从而影响细胞收缩性和黏附性的已知能力有关。LAT-A对虹膜和CM的作用可能具有重要的生理和临床意义。